Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
SCHENK LYNN
Director at Sempra · Director at Biogen. Filing since 15 Oct 2007.
CIK 0001236534
SRE
Sempra
Director · 3 trades
BIIB
Biogen
Director · 11 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SRE
Sempra
15 Apr 2019
Director
Sold, plan not stated
5,000
$644.60K
30.7%
SRE
Sempra
2 Jan 2019
Director
Sold, plan not stated
5,000
$535.45K
30.7%
SRE
Sempra
19 Jun 2014
Director
Sold, plan not stated
2,500
$262.50K
48.9%
BIIB
Biogen
15 Jan 2014
Director
Sold, plan not stated
1,000
$297.48K
24.4%
BIIB
Biogen
2 Dec 2013
Director
Sold, plan not stated
1,000
$291.71K
19.6%
BIIB
Biogen
1 Nov 2013
Director
Sold, plan not stated
1,000
$245.00K
16.4%
BIIB
Biogen
1 Oct 2013
Director
Sold, plan not stated
1,000
$242.85K
14.1%
BIIB
Biogen
11 Sep 2013
Director
Sold, plan not stated
900
$211.73K
21.3%
BIIB
Biogen
10 Jun 2013
Director
Sold, plan not stated
2,000
$451.63K
40.7%
BIIB
Biogen
2 May 2012
Director
Sold, plan not stated
8,480
$1.14M
54.4%
BIIB
Biogen
2 May 2012
Director
Sold, plan not stated
5,975
$806.63K
67.3%
BIIB
Biogen
20 Apr 2011
Director
Sold, plan not stated
37,275
$3.18M
82.4%
BIIB
Biogen
30 Dec 2010
Director
Sold, plan not stated
15,000
$1.00M
65.3%
BIIB
Biogen
15 Oct 2007
Director
Sold, plan not stated
63,000
$5.17M
93.6%
14 decisions on file.